introduction link altered iron balance infection recognized since mid-twentieth century iron essential mineral human body playing critical role oxygen transport part hemoglobin well various physiological function however unbound iron generate toxic free radical damage host tissue therefore iron concentration blood maintained low possible tightly chaperoned transferrin simultaneously iron also essential nutrient bacteria synthesize secrete siderophores small molecule high affinity iron extracellularly acquire iron therefore infection host pathogen compete iron acquisition discovery hepcidin key regulator iron metabolism early 2000s considered major turning point field hepcidin bind ferroportin responsible iron transport promotes intracellular degradation ferroportin expressed cell small intestinal epithelial cell macrophage pump iron blood hepcidin regulates iron utilization cycle vivo directly inhibiting ferroportin hepcidin production subject multifaceted regulation inflammation body iron level tissue injury oxygenation status inflammation hepatocytes produce hepcidin via interleukin-6 il-6 signal transducer activator transcription stat3 -mediated pathway another factor involved iron metabolism secreted glycoprotein lipocalin-2 lcn2 neutrophil gelatinase-associated lipocalin ngal another name lcn2 siderocallin 24p3 belongs group lipophilic small-molecule transporter although lcn2 doe bind iron isolation primarily bind bacterial siderophores inhibiting iron uptake thus limiting bacterial iron uptake infection neutrophil macrophage epithelial cell cell produce lcn2 inflammatory mediator tumor necrosis factor tnf il-1β il-6 cause reaction implying involvement innate immune system antimicrobial iron restriction strategy factor involved iron metabolism becoming increasingly clear relationship iron metabolism infection often presented context chronic inflammation anemia addition current understanding relationship iron metabolism infection particularly acute infection model primarily derived animal study thus remains scope exploration understanding iron metabolism realm human infectious disease addition modern context emergence drug-resistant bacteria new approach pathophysiology infectious disease urgently needed iron metabolism considered particularly attractive target background research aim investigate infectious disease axis iron metabolism focusing hepcidin lcn2 end comprehensively analyzed iron metabolism inflammatory marker bloodstream infection using clinical sample result table summarizes participant clinical characteristic study included clinical sample patient median age year 50.0 male among blood test included study missing value neutrophil count case sample ferritin case sample nineteen 39.6 case hospital-onset 60.4 community-onset median sequential organ failure assessment sofa score point range 0–14 point death observed total patient 62.5 diagnosed sepsis underlying condition included urinary tract 25.0 biliary 20.8 catheter-related 14.6 infection total organism detected blood culture six case multiple organism table escherichia coli commonly isolated 27.3 followed klebsiella pneumoniae 9.1 oxytoca 5.5 aeruginosa 5.5 fungi detected five case candida spp table characteristic participant full size table iron kinetics associated marker clinical course bloodstream infection temporal change iron metabolism inflammation marker shown fig context study value measured d10 considered baseline value measured compared blood level inflammatory marker interleukin il-6 c-reactive protein crp well white blood cell wbc count rose infection acute period additionally blood level iron-related hepcidin lcn2 also increased compared d10 contrast iron level decreased 95.8 case iron level normal range 40–188 μg/dl recovery phase d10 immune system treatment brought infection control wbc level il-6 crp hepcidin lcn2 substantially decreased compared acute phase infection iron level showed recovery trend increased within reference range 62.5 case study median change iron concentration μg/dl maximum μg/dl iqr 21–63 μg/dl table present representative value measured parameter point another marker related iron metabolism ferritin increased acute phase decreased like acute-phase protein contrast unsaturated iron-binding capacity uibc total iron-binding capacity tibc like iron decreased acute phase infection tibc increased significantly recovery phase whereas uibc figure change time marker iron metabolism inflammation bloodstream infection change time inflammatory iron parameter patient bloodstream infection wbc il-6 crp iron hep lcn2 level measured time point shown box-and-whisker plot thick line represents median box represent interquartile range median point connected solid line logarithmic scale used il-6 y-axis measurement compared point p-values calculated using wilcoxon signed-rank test statistically significant item marked asterisk wbc white blood cell count il-6 interleukin-6 crp c-reactive protein hep hepcidin lcn2 lipocalin-2 full size image table laboratory result time point full size table furthermore line graph fig show case-specific iron inflammatory marker trend hospital-onset case community-onset case excluded make time onset positive blood culture uniform possible measurement point compared related pair result typical variation pattern appeared parameter consistent result described among crp lcn2 highest case 89.5 78.9 respectively iron lowest 89.5 case hepcidin hand highest case 68.4 indicating earlier hepcidin elevation acute phase comparison based disease severity clinical course measure severity blood test result compared group point acute phase participant split two group based presence absence sepsis fig table among iron metabolism indicator lcn2 significantly higher sepsis 0.01 0.03 respectively without sepsis laboratory study d10 revealed significant difference figure comparison laboratory data without sepsis participant divided two group sepsis non-sepsis group wbc il-6 crp iron hep lcn2 blood level measured compared two group box-and-whisker plot thick line represents median box represent interquartile range median point connected solid line logarithmic scale used il-6 y-axis measurement compared point p-values calculated using wilcoxon signed-rank test statistically significant item marked asterisk wbc white blood cell count il-6 interleukin-6 crp c-reactive protein hep hepcidin lcn2 lipocalin-2 full size image also examined correlation sofa score various measured parameter time point ass temporal progression disease severity table excluding parameter intrinsic sofa score platelet count creatinine total bilirubin significant correlation sofa score observed presepsin il-6 lcn2 presepsin also showing correlation marker related iron metabolism lcn2 including hepcidin showed clear correlation sofa score table correlation laboratory parameter sofa score time full size table additionally evaluate dynamic iron marker persistent inflammation based previous report proposing criterion persistent inflammation immunosuppression catabolism syndrome patient crp level exceeding 2.0 mg/dl d10 median 0.36 mg/dl defined persistent inflammation group patient control group two group laboratory value d10 compared table notably iron level significantly lower persistent inflammation group µg/dl iqr 26–44 compared control group µg/dl iqr 39–91 0.01 furthermore hemoglobin albumin total bilirubin significantly lower persistent inflammation group il-6 presepsin lcn2 significantly higher compared control group table comparison laboratory data without persistent inflammation full size table correlation item measured correlation analytes evaluated sample d10 fig test showed moderate negative correlation iron concentration crp 0.69 neutrophil 0.55 il-6 0.55 lcn2 0.52 weak negative correlation wbc count 0.48 presepsin 0.45 hepcidin 0.40 hand iron concentration showed weak positive correlation albumin tibc 0.39 hepcidin showed moderate positive correlation crp 0.60 il-6 0.60 ferritin 0.52 lcn2 showed moderate positive correlation crp 0.59 neutrophil 0.59 il-6 0.58 wbc 0.51 table show correlation coefficient measured parameter item figure correlation iron inflammatory marker scatterplot matrix shown white blood cell count inflammatory marker iron metabolism marker probability ellipsis 0.95 spearman rank correlation coefficient described logarithmic scale used il-6 axis table list additional variable wbc white blood cell count il-6 interleukin-6 crp c-reactive protein hep hepcidin lcn2 lipocalin-2 full size image principal component analysis pca performed sample measured d10 table display eigenvectors principal component pc1 pc4 first two accounted 41.6 variation data set pc1 variable related infection inflammation wbc neutrophil presepsin predominated high positive eigenvector value pc2 albumin transferrin represented tibc predominated large positive eigenvector value score plot revealed data distribution without outlier fig sample appeared similar clustering pattern d10 sample revealed distinct distribution shift d10 indicates dynamic change influence parameter time loading plot fig hepcidin lcn2 found cluster wbc neutrophil presepsin crp conversely iron clustered opposite quadrant parameter suggesting negative correlation figure principal component analysis measured item principal component analysis identified first two principal component explained 41.6 variation dataset score plot showing principal component score sample circle filled circle triangle indicate d10 respectively loading plot showing item loading principal component item clustered close together graph indicate vary manner wbc white blood cell count neu neutrophil count hemoglobin plt platelet count alb albumin cre creatinine tbil total bilirubin il-6 interleukin-6 crp c-reactive protein p-sep presepsin tibc total iron-binding capacity uibc unsaturated iron-binding capacity tsat transferrin saturation fer ferritin hep hepcidin lcn2 lipocalin-2 full size image discussion study comprehensively evaluated host iron metabolism bloodstream infection using clinical blood sample detailed temporal dynamic several parameter related iron metabolism inflammatory marker focusing dynamic hepcidin master regulator iron rapid increase acute phase typically characterized time course blood hepcidin level outcome consistent prior experiment using lipopolysaccharide injection typhoid infection human volunteer contrast hepcidin iron level decreased rapidly although iron level tended decrease later increase hepcidin level acute phase present study targeted bloodstream infection effect hepcidin may contribute host innate immunity reducing amount iron extracellular pathogen environment thereby inhibiting iron acquisition observation consistent previous finding contrast iron essential nutrient host homeostasis persistent iron deficiency blood avoided study hypoferremia acute phase transient infection controlled resolved progressive decrease hepcidin level corresponding increase iron level inflammation persisted iron level remained low prolonged period time course analysis provides clearer comprehensive understanding human body manages regulates iron critical period current study also includes blood level another iron-related factor lcn2 engaged several physiological pathophysiological process inflammation infection immune response metabolic homeostasis present result show blood level lcn2 increase acute phase systemic infection decrease recovery phase consistent previous report using mouse model furthermore lcn2 level significantly elevated acute phase sepsis showed significant correlation sofa score indicating potential marker sepsis severity lcn2 knockout mouse also showed protective role sepsis organ damage mortality worse lcn2 knockout mouse wild-type mouse injection therefore present result suggest important action lcn2 sepsis pathogenesis warranting study lcn2 considered effective biomarker acute kidney injury addition strong inflammatory response lcn2 level may affected kidney injury associated bloodstream infection including sepsis present study however correlation found creatinine lcn2 level effect considered limited study present study reiterated close relationship inflammation iron metabolism acute systemic infection possible starting point finding involvement inflammatory cytokine il-6 released immune cell response infection injury previous report plasma iron tibc level decreased recovered il-6 administration animal model general blood level il-6 increase rapidly early stage infection hour day acute-phase protein like crp ferritin hepcidin lcn2 induced il-6 hand il-6 decrease albumin transferrin production effect il-6 consistent result current study including time trend measure correlation pca recent year spread multidrug-resistant bacteria become global problem development antibiotic new mechanism action urgently needed setting bacterial iron transport mechanism attractive site action antimicrobial agent siderophore cephalosporin efficiently penetrate outer membrane bacterial iron transport system forming iron chelate complex reportedly effective multidrug-resistant gram-negative bacteria therefore dynamic iron metabolism clinical course study expected useful effective use antimicrobial agent iron-deficient condition bacteria upregulate siderophore iron transporter system consistent finding vitro study shown concentration iron culture medium affect antimicrobial activity siderophore cephalosporin lower minimum inhibitory concentration iron-deficient situation therefore hypoferremia shown study acute phase systemic infection may also enhance efficacy antimicrobial agent vivo several limitation research first single-center study conducted university hospital included relatively small number patient diverse clinical background possibility unintentional selection bias excluded second possible establish baseline value parameter disease onset difficult determine onset bloodstream infection advance value measured recovery phase d10 used comparison third death study could examine relationship poor prognosis iron metabolism bloodstream infection address issue sepsis group persistent inflammation group established investigate difference severity pathophysiology nevertheless despite limitation believe study shed light intricate mechanism iron metabolism systemic infection provides foundation future study conclusion suggested hypoferremia due effect hepcidin decrease iron environment extracellular pathogen increase lcn2 level directly inhibits siderophores acute phase infection effect hepcidin lcn2 associated inflammatory response prevents iron acquisition pathogen manner era prevalent drug-resistant bacteria detailed understanding infection–iron axis clinical practice critical represents potential advance diagnosis treatment infectious disease future method ethic approval consent participate study conducted compliance declaration helsinki current ethical guideline ethic committee niigata university approval number 2015-2301 approved study including waiver written informed consent due use residual blood sample study absence novel invasive procedure patient information study goal opt-out option provided official website niigata university school medicine study participant design niigata university medical dental hospital bed tertiary urban hospital study included case bloodstream infection study period march december patient new positive blood culture reviewed daily positive blood culture confirmed diagnosis bloodstream infection single positive culture normal skin flora excluded case clinical course day first positive blood culture defined day illness previous vivo report indicated hepcidin reach maximum concentration c-reactive protein crp 2–3 day based finding study included test result item two point day illness acute phase infection additionally first day blood testing day illness defined d10 treated indicator recovery phase purpose study baseline value parameter defined based measurement taken d10 eligible patient adult aged year blood test appropriate time residual blood sample available treating physician obtained laboratory result used study practice missing data additional testing residual plasma sample d10 stored 80°c used additional blood sample collected study finally sample case obtained sample case excluded enough sample additional testing data collection clinical information age gender medical history medication microorganism caused infection gathered computerized medical record ass number severity organ failure case sofa score obtained time sepsis diagnosis based international criterion laboratory test result included wbc count reference range 3.3–8.6 cell 10^9/l neutrophil count 1.6–6.0 cell 10^9/l hemoglobin male 137–168 female 116–148 g/l platelet count 158–348 cell 10^9/l albumin 41–51 g/l creatinine male 0.65–1.07 female 0.46–0.79 mg/dl total bilirubin 0.4–1.5 mg/dl crp 0.15 mg/dl additionally residual stored plasma used measure il-6 pg/ml presepsin pg/ml iron 40–188 µg/dl tibc 250–460 µg/dl uibc 191–269 µg/dl ferritin male 13–277 female 5–152 ng/ml transferrin saturation tsat 20–50 hepcidin lcn2 using quick chemiluminescent enzyme immunoassay plasma presepsin determined pathfast immunoanalyzer lsi medience corporation tokyo japan tibc measurement substituted transferrin tsat based ratio iron tibc tsat iron tibc hepcidin several isoforms amino acid hepcidin-25 active form hepcidin included study previously reported surface-enhanced laser desorption/ionization time-of-flight mass spectrometry seldi-tof used measure plasma hepcidin level although reference value hepcidin determined median value healthy volunteer measured 19.1 ng/ml using method enzyme-linked immunosorbent assay kit hycult biotech pennsylvania usa determined lcn2 plasma level internal control according kit instruction statistical analysis jmp 14.2 institute inc. usa used analyze data shapiro–wilk test employed ascertain whether continuous factor normal distribution continuous variable summarized mean standard error case normal distribution median interquartile range iqr case distribution normal student t-test applied evaluation two group two-tailed f-test determined equivariance welch t-test used two group unequally distributed wilcoxon signed-rank test applied distribution non-normal wilcoxon signed-rank sum test applied analyze paired data non-normal distribution statistical significance defined 0.05 strength direction linear connection two variable evaluated using correlation coefficient pearson correlation coefficient used factor normally distributed otherwise spearman correlation value applied missing value correlation estimated using pairwise method correlation coefficient absolute value 0.3 0.5 considered weak correlation 0.5 0.7 moderate correlation 0.7 high correlation multidimensional data structure represented succinctly using pca also used visualize data characteristic show connection variable construct principal component eigenvectors covariance matrix data representing direction data explain maximum amount variance score plot graph calculated value component relation value adjusted mean standard deviation loading plot graph unrotated loading matrix variable component value close indicate greater effect component